A detailed history of Israel Englander (Millennium Management LLC) transactions in Xencor Inc stock. As of the latest transaction made, Millennium Management LLC holds 820,871 shares of XNCR stock, worth $17.3 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
820,871
Previous 822,976 0.26%
Holding current value
$17.3 Million
Previous $18.2 Million 14.68%
% of portfolio
0.01%
Previous 0.01%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$18.21 - $24.5 $38,332 - $51,572
-2,105 Reduced 0.26%
820,871 $15.5 Million
Q1 2024

May 15, 2024

BUY
$18.65 - $26.52 $8.82 Million - $12.5 Million
472,762 Added 134.99%
822,976 $18.2 Million
Q4 2023

Feb 14, 2024

BUY
$16.53 - $21.42 $475,105 - $615,653
28,742 Added 8.94%
350,214 $7.44 Million
Q2 2023

Aug 14, 2023

BUY
$24.77 - $29.9 $7.72 Million - $9.32 Million
311,624 Added 3164.34%
321,472 $8.03 Million
Q1 2023

May 15, 2023

SELL
$25.95 - $36.95 $799,130 - $1.14 Million
-30,795 Reduced 75.77%
9,848 $275,000
Q4 2022

Feb 14, 2023

BUY
$24.79 - $30.86 $790,082 - $983,539
31,871 Added 363.33%
40,643 $1.06 Million
Q3 2022

Nov 14, 2022

SELL
$24.62 - $32.44 $5.86 Million - $7.72 Million
-237,995 Reduced 96.45%
8,772 $228,000
Q2 2022

Aug 15, 2022

SELL
$19.74 - $29.01 $144,220 - $211,947
-7,306 Reduced 2.88%
246,767 $6.75 Million
Q1 2022

May 16, 2022

BUY
$26.68 - $41.63 $6.16 Million - $9.61 Million
230,923 Added 997.51%
254,073 $6.78 Million
Q4 2021

Feb 14, 2022

BUY
$33.67 - $43.44 $85,521 - $110,337
2,540 Added 12.32%
23,150 $929,000
Q3 2021

Nov 15, 2021

SELL
$30.65 - $35.68 $3.57 Million - $4.15 Million
-116,376 Reduced 84.95%
20,610 $673,000
Q2 2021

Aug 16, 2021

BUY
$34.33 - $44.68 $3.73 Million - $4.85 Million
108,576 Added 382.18%
136,986 $4.73 Million
Q1 2021

May 17, 2021

BUY
$40.81 - $53.88 $629,616 - $831,260
15,428 Added 118.84%
28,410 $1.22 Million
Q4 2020

Feb 16, 2021

BUY
$36.63 - $47.63 $74,835 - $97,308
2,043 Added 18.68%
12,982 $566,000
Q3 2020

Nov 16, 2020

BUY
$30.09 - $43.02 $329,154 - $470,595
10,939 New
10,939 $424,000
Q2 2020

Aug 14, 2020

SELL
$27.76 - $33.42 $1.57 Million - $1.89 Million
-56,588 Closed
0 $0
Q1 2020

May 14, 2020

BUY
$20.69 - $37.79 $1.17 Million - $2.14 Million
56,588 New
56,588 $1.69 Million
Q3 2019

Nov 14, 2019

SELL
$33.73 - $46.27 $55.8 Million - $76.6 Million
-1,655,086 Closed
0 $0
Q2 2019

Aug 15, 2019

BUY
$29.6 - $40.93 $20 Million - $27.6 Million
674,021 Added 68.7%
1,655,086 $67.7 Million
Q2 2019

Aug 14, 2019

BUY
$29.6 - $40.93 $29 Million - $40.2 Million
981,065 New
981,065 $10 Million
Q2 2018

Aug 14, 2018

SELL
$28.41 - $42.41 $1.25 Million - $1.86 Million
-43,936 Closed
0 $0
Q1 2018

May 15, 2018

SELL
$21.18 - $33.78 $476,507 - $759,982
-22,498 Reduced 33.87%
43,936 $1.32 Million
Q4 2017

Feb 14, 2018

BUY
$19.29 - $24.83 $1.28 Million - $1.65 Million
66,434
66,434 $1.46 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.26B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track Israel Englander's Portfolio

Track Israel Englander Portfolio

Follow Israel Englander (Millennium Management LLC) and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Millennium Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Millennium Management LLC and Israel Englander with notifications on news.